PGNY Progyny Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: PGNY

Price (delayed)

$25.83

Market cap

$1.98B

P/E Ratio

26.91

Dividend/share

N/A

EPS

$0.96

Enterprise value

$1.85B

?
Relative Growth: Rel. Growth: 93
Relative Strength: Rel. Strength: 66
Relative Valuation: Rel. Valuation: 67
Relative Profitability: Rel. Profitability: 69
Highlights
The EPS has surged by 57% year-on-year and by 20% since the previous quarter
The net income has grown by 48% YoY and by 16% from the previous quarter
PGNY's equity is down by 12% year-on-year but it is up by 3.2% since the previous quarter
PGNY's quick ratio is down by 21% year-on-year
Sector: Healthcare
Industry: Health Information Services
Website: http://www.progyny.com

Key stats

What are the main financial stats of PGNY

PGNY stock price

How has the Progyny stock price performed over time
Intraday
-1.56%
1 week
-5.66%
1 month
0.7%
1 year
20.31%
YTD
0.58%
QTD
-10.41%

Financial performance

How have Progyny's revenue and profit performed over time
Revenue
$1.31B
Gross profit
$322.09M
Operating income
$112.13M
Net income
$78.63M
Gross margin
24.6%
Net margin
6%
The net income has grown by 48% YoY and by 16% from the previous quarter
Progyny's operating income has increased by 46% YoY and by 16% QoQ
The company's net margin rose by 40% YoY and by 15% QoQ
PGNY's operating margin is up by 39% year-on-year and by 15% since the previous quarter

Price vs fundamentals

How does PGNY's price correlate with its fundamentals

Growth

What is Progyny's growth rate over time

Valuation

What is Progyny stock price valuation
PGNY P/E details
P/E
26.91
P/B
4.46
P/S
1.54
EV/EBIT
15.45
EV/EBITDA
14.75
EV/Sales
1.41
The EPS has surged by 57% year-on-year and by 20% since the previous quarter
The stock's price to earnings (P/E) is 48% less than its 5-year quarterly average of 52.6 and 10% less than its last 4 quarters average of 30.5
PGNY's price to book (P/B) is 41% lower than its 5-year quarterly average of 7.7 but 16% higher than its last 4 quarters average of 3.9
PGNY's equity is down by 12% year-on-year but it is up by 3.2% since the previous quarter
PGNY's price to sales (P/S) is 57% lower than its 5-year quarterly average of 3.6 but 4% higher than its last 4 quarters average of 1.5
The revenue is up by 6% year-on-year

Efficiency

How efficient is Progyny business performance
Progyny's return on assets has increased by 39% YoY and by 19% QoQ
The company's return on equity rose by 38% YoY and by 20% QoQ
The return on sales has grown by 26% year-on-year and by 11% since the previous quarter
PGNY's return on invested capital is up by 26% year-on-year and by 20% since the previous quarter

Dividends

What is PGNY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PGNY.

Financial health

How did Progyny financials performed over time
PGNY's total assets is 173% more than its total liabilities
PGNY's quick ratio is down by 21% year-on-year
Progyny's current ratio has decreased by 21% YoY
The company's debt is 95% lower than its equity
The company's debt fell by 12% YoY and by 3.3% QoQ
PGNY's equity is down by 12% year-on-year but it is up by 3.2% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.